- Home
- ARBB vs CYCN Comparison
ARBB vs CYCN Comparison
Compare ARBB & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- CYCN
- Stock Information
- Founded
- ARBB 1997
- CYCN 2018
- Country
- ARBB Singapore
- CYCN United States
- Employees
- ARBB N/A
- CYCN N/A
- Industry
- ARBB EDP Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- CYCN Health Care
- Exchange
- ARBB Nasdaq
- CYCN Nasdaq
- Market Cap
- ARBB 8.8M
- CYCN 8.0M
- IPO Year
- ARBB 2023
- CYCN N/A
- Fundamental
- Price
- ARBB $4.96
- CYCN $2.39
- Analyst Decision
- ARBB Strong Buy
- CYCN
- Analyst Count
- ARBB 1
- CYCN 0
- Target Price
- ARBB $20.00
- CYCN N/A
- AVG Volume (30 Days)
- ARBB 7.1K
- CYCN 22.7K
- Earning Date
- ARBB 11-03-2025
- CYCN 08-05-2025
- Dividend Yield
- ARBB N/A
- CYCN N/A
- EPS Growth
- ARBB N/A
- CYCN N/A
- EPS
- ARBB N/A
- CYCN N/A
- Revenue
- ARBB $24,425,491.00
- CYCN $2,174,000.00
- Revenue This Year
- ARBB N/A
- CYCN N/A
- Revenue Next Year
- ARBB N/A
- CYCN N/A
- P/E Ratio
- ARBB N/A
- CYCN N/A
- Revenue Growth
- ARBB N/A
- CYCN N/A
- 52 Week Low
- ARBB $3.22
- CYCN $1.27
- 52 Week High
- ARBB $18.60
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- ARBB 55.99
- CYCN 43.45
- Support Level
- ARBB $4.06
- CYCN $2.36
- Resistance Level
- ARBB $4.36
- CYCN $2.59
- Average True Range (ATR)
- ARBB 0.28
- CYCN 0.22
- MACD
- ARBB 0.13
- CYCN 0.02
- Stochastic Oscillator
- ARBB 100.00
- CYCN 15.00
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.